Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Total Non-Current Liabilities (2016 - 2022)

Updated

Avenue Therapeutics' Total Non-Current Liabilities came in at $970,000 for Q4 2022.

Analysis

Avenue Therapeutics (ATXI) Total Non-Current Liabilities (2016 - 2022) Analysis & Trends

Going back to Q4 2016, Avenue Therapeutics' Total Non-Current Liabilities data covers 6 quarters.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -19.0% (FY2017 to FY2022).
  • The Q4 2022 figure represents the highest quarterly Total Non-Current Liabilities since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 102.65 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 106.45 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 97.04 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 970,000.00
Dec 31, 2017 2.79 Mn
Sep 30, 2017 1.99 Mn
Jun 30, 2017 7.55 Mn
Mar 31, 2017 8.83 Mn
Dec 31, 2016 8.13 Mn
API Access

Avenue Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ATXI&period=max&api_key=YOUR_API_KEY